Quality Credentials ISO/IEC17025 and OECD GLP with NATA accreditation position Agilex as a trusted, compliant partner for regulated bioanalysis and toxicology across preclinical to clinical stages in the Asia Pacific.

Integrated Offering Market Agilex as a one-stop CRO with integrated bioanalysis, toxicology, and gene therapy capabilities, plus access to TetraQ Brisbane for GLP in vivo studies to streamline programs and reduce vendor handoffs.

Gene Therapy Focus Invested in advanced immunoassay and cell & gene therapy platforms (Gyrolab xPlore, Luminex, ddPCR) to win projects from vaccines, cell therapies, and complex biologics requiring specialized analytics.

APAC Growth Recent facility expansion to Brisbane and ongoing regional capacity enable faster starts, local regulatory familiarity, and scalable support for Australian, New Zealand, and wider APAC biotechs and pharma groups.

Credibility Partnerships Industry recognition and partnerships (awards in 2022; SGS collaboration in 2023) provide compelling buying signals for enterprise customers seeking proven providers with quality, scale, and international references.